Search In this Thesis
   Search In this Thesis  
العنوان
Study Of The Role Of Kisspeptin In Constitutional Delayed Puberty In Boys /
المؤلف
Ellotf, Mohamed Ragab Mohamed.
هيئة الاعداد
باحث / محمد رجب محمد اللطف
مشرف / عبدالله محمد عطية
مشرف / بلال عبد المحسن منتصر
الموضوع
Puberty, Delayed. Puberty - Juvenile literature. Growth disorders. Teenage boys - Physiology.
تاريخ النشر
2018.
عدد الصفحات
126 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب التناسلي
الناشر
تاريخ الإجازة
16/2/2019
مكان الإجازة
جامعة المنوفية - كلية الطب - الأمراض الجلدية التناسلية
الفهرس
Only 14 pages are availabe for public view

from 136

from 136

Abstract

Delayed puberty is considered when the boy reaches 14 years old and didn’t start pubertal manifestation or 18 years without it’s completion. This delay may be pathological as in cases of hypogonadotrophic and hypergonadotrophic hypogonadism or constitutional delay (CDP). The latter is the most common type of pubertal delay.
constitutional delayed puberty is considered as the delay of normal, as the boy enters puberty spontaneously but delayed < 2 years of it’s normal onset and complete it before the age of 18 years, without any significant permanent effect on his sexual or reproductive functions.
The exact etiopathology of CDP is still unclear and many speculations exist in this regard as; genetic factors, nutrition or environmental causes. etc.
Kisspeptin is a relatively newly discovered hormone. The KISS1/KISS1R system is a critical component of the HPG axis. Kisspeptin plays a role in regulating puberty and fertility through its action on hypothalamic gonadotropin releasing hormone production. It’s exact role in CDP is unclear and very few researches exist.
So, we aimed by this work to spot light on it’s relation to CDP through measuring it’s level and to find out its correlation to testosterone, FSH and prolactin in such boys.
The study was carried out on 25 boys with CDP (Tanner’s stages I, II & III) as the patient group and another similar number of age matched, full pubertal boys (Tanner’s stage V) as a control group.
For all; after thorough history and clinical examination, total testosterone, FSH, prolactin and kisspeptin were measured.
The results were statistically analyzed and showed that:
1. No significant differences between chronological and bone age of the control group, while in CDP group; bone age is significantly delayed compared to their chronological age as well as the bone age of the control group.
2. Weight and height are significantly less in CDP group than that of the control.
3. Serum Testosterone is significantly lower in CDP, compared to control group.
4. Serum FSH as well is significantly less than that of the control group.
5. Serum Prolactin showed no significant differences between both groups.
6. Serum kisspeptin is much significantly lower in CDP group, compared to the control.
7. Serum kisspeptin is positively correlated to both testosterone & FSH and have no relation with prolactin.